Cytomegalovirus and HLA-A, B, and DR locus interactions: Impact on renal transplant graft survival

This publication has 23 references indexed in Scilit:

• Risk factors for cytomegalovirus infection and disease in renal transplant recipients: HLA-DR7 and triple therapy
  Transplant International, 1994
• Factors influencing the occurrence of active cytomegalovirus (CMV) infections after organ transplantation
  Clinical and Experimental Immunology, 1993
• Symptomatic Cytomegalovirus Infection in Renal Transplant Recipients Given Either Minnesota Antilymphoblast Globulin (MALG) or OKT3 for Rejection Prophylaxis
  American Journal of Kidney Diseases, 1993
• Increased frequency of CMV infection in HLA-DR7 matched renal allograft recipients
  The Lancet, 1993
• Enhancement of class I HLA antigen expression by cytomegalovirus: Role in amplification of virus infection
  Journal of Medical Virology, 1988
• CMV INFECTION, CLASS II ANTIGEN EXPRESSION, AND HUMAN KIDNEY ALLOGRAFT REJECTION
  Transplantation, 1986
• HLA-DRw6 as a risk factor for active cytomegalovirus but not for herpes simplex virus infection after renal allograft transplantation.
  BMJ, 1985
• Renal graft dysfunction during infection with cytomegalovirus: association with IgM lymphocytotoxins and HLA-DR3 and DR7.
  BMJ, 1983
• Cytomegalovirus Infections Following Renal Transplantation
  Clinical Infectious Diseases, 1981
• CYTOMEGALOVIRUS AS A RISK FACTOR IN RENAL TRANSPLANTATION
  Transplantation, 1980